Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Mira, Nuno P ^a,b   Madeira, Andreia ^a,b   Moreira, Ana Sílvia ^a   Coutinho, Carla P ^a   Sá Correia, Isabel ^a,b  

^a Instituto de Biotecnologia e Bioengenharia Lisboa   (Portugal)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MUCIN; OXYGEN; PIPERACILLIN; TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOSYNTHESIS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA INFECTION; CLONAL VARIATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; IRON TRANSPORT; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; MOLECULAR CLONING; NONHUMAN; PROTEIN BINDING; RNA TRANSLATION; TRANSCRIPTOMICS; UPREGULATION; ADAPTATION; GENETICS; HUMAN GENOME; MICROBIOLOGY; PHYSIOLOGY; TRACHEA;

ADAPTATION, PHYSIOLOGICAL; ANTI-INFECTIVE AGENTS; BURKHOLDERIA CENOCEPACIA; CYSTIC FIBROSIS; GENES, BACTERIAL; GENOME, HUMAN; HUMANS; TRACHEA;

EID: 83755186155     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028831     Document Type: Article

References (78)

1. Mahenthiralingam E, Urban TA, Goldberg JB, (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Micro 3: 144-156.
2. Burns JL, (2007) Antibiotic resistance of Burkholderia spp. In: bioscience H, editors. Bukholderia: Molecular Microbiology and Genomics Norfolk New Horizon.
3. Leitão J, Sousa S, Cunha M, Salgado M, Melo-Cristino J, et al. (2008) Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center. Eur J Clin Microbiol Infect Dis 27: 1101-1111.
4. Doring G, Parameswaran IG, Murphy TF, (2011) Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol Rev 35: 124-146.
5. Harrison F, (2007) Microbial ecology of the cystic fibrosis lung. Microbiology 153: 917-923.
6. Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, et al. (2009) Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 200: 118-130.
7. Hoffman LR, Richardson AR, Houston LS, Kulasekara HD, Martens-Habbena W, et al. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6: e1000712.
8. Jain M, Bar-Meir M, McColley S, Cullina J, Potter E, et al. (2008) Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection. Transl Res 152: 257-264.
9. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103: 8487-8492.
10. Son MS, Matthews WJ Jr, Kang Y, Nguyen DT, Hoang TT, (2007) In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun 75: 5313-5324.
11. Spencer DH, Kas A, Smith EE, Raymond CK, Sims EH, et al. (2003) Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol 185: 1316-1325.
12. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, et al. (2011) Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A 108: 7481-7486.
13. Cunha MV, Leitão JH, Mahenthiralingam E, Vandamme P, Lito L, et al. (2003) Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol 41: 4113-4120.
14. Cunha MV, Pinto-de-Oliveira A, Meirinhos-Soares L, Salgado MJ, Melo-Cristino J, et al. (2007) Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the Major Portuguese Cystic Fibrosis Center. J Clin Microbiol 45: 1628-1633.
15. Coutinho C, Carvalho CCR, Madeira A, Pinto-de-Oliveira A, Sá-Correia I, (2011) Burkholderia cenocepacia clonal phenotypic variation during three and a half years of residence in the lungs of a cystic fibrosis patient. Infect Immun 79: 2950-2960.
16. Madeira A, Santos PM, Coutinho CP, Pinto-de-Oliveira A, Sá-Correia I, (2011) Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy. PROTEOMICS 11: 1313-1328.
17. Cunha MV, Leitao JH, Mahenthiralingam E, Vandamme P, Lito L, et al. (2003) Molecular Analysis of Burkholderia cepacia Complex Isolates from a Portuguese Cystic Fibrosis Center: a 7-Year Study. J Clin Microbiol 41: 4113-4120.
18. Drevinek P, Mahenthiralingam E, (2010) Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clinical Microbiology and Infection 16: 821-830.
19. Govan JR, Brown AR, Jones AM, (2007) Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiology 2: 153-164.
20. Cunha MV, Pinto-de-Oliveira A, Meirinhos-Soares L, Salgado MJ, Melo-Cristino J, et al. (2007) Exceptionally High Representation of Burkholderia cepacia among B. cepacia Complex Isolates Recovered from the Major Portuguese Cystic Fibrosis Center. J Clin Microbiol 45: 1628-1633.
21. Oliver A, Canton R, Campo P, Baquero F, Blazquez J, (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 1251-1253.
22. Holden MT, Seth-Smith HM, Crossman LC, Sebaihia M, Bentley SD, et al. (2009) The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 191: 261-277.
23. Baldwin A, Sokol PA, Parkhill J, Mahenthiralingam E, (2004) The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun 72: 1537-1547.
24. Drevinek P, Holden MT, Ge Z, Jones AM, Ketchell I, et al. (2008) Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infect Dis 8: 121.
25. Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, et al. (2005) Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 43: 4665-4673.
26. Menard A, de Los Santos PE, Graindorge A, Cournoyer B, (2007) Architecture of Burkholderia cepacia complex sigma70 gene family: evidence of alternative primary and clade-specific factors, and genomic instability. BMC Genomics 8: 308.
27. Bazzini S, Udine C, Sass A, Pasca MR, Longo F, et al. (2011) Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS One 6: e18902.
28. Eaves DJ, Ricci V, Piddock LJ, (2004) Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob Agents Chemother 48: 1145-1150.
29. Buroni S, Pasca MR, Flannagan RS, Bazzini S, Milano A, et al. (2009) Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol 9: 200.
30. Guglierame P, Pasca MR, De Rossi E, Buroni S, Arrigo P, et al. (2006) Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol 6: 66.
31. Moore RA, Hancock RE, (1986) Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother 30: 923-926.
32. Aronoff SC, (1988) Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents Chemother 32: 1636-1639.
33. Jaffe A, Chabbert YA, Semonin O, (1982) Role of porin proteins OmpF and OmpC in the permeation of beta-lactams. Antimicrob Agents Chemother 22: 942-948.
34. Cunningham L, Pitt M, Williams HD, (1997) The cioAB genes from Pseudomonas aeruginosa code for a novel cyanide-insensitive terminal oxidase related to the cytochrome bd quinol oxidases. Mol Microbiol 24: 579-591.
35. Barth AL, Pitt TL, (1996) The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45: 110-119.
36. Thomas SR, Ray A, Hodson ME, Pitt TL, (2000) Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55: 795-797.
37. Cantin AM, (1994) Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J Clin Invest 93: 606-614.
38. Kertesz MA, (2000) Riding the sulfur cycle-metabolism of sulfonates and sulfate esters in gram-negative bacteria. FEMS Microbiol Rev 24: 135-175.
39. Jansen HJ, Hart CA, Rhodes JM, Saunders JR, Smalley JW, (1999) A novel mucin-sulphatase activity found in Burkholderia cepacia and Pseudomonas aeruginosa. J Med Microbiol 48: 551-557.
40. Agnoli K, Lowe CA, Farmer KL, Husnain SI, Thomas MS, (2006) The ornibactin biosynthesis and transport genes of Burkholderia cenocepacia are regulated by an extracytoplasmic function sigma factor which is a part of the Fur regulon. J Bacteriol 188: 3631-3644.
41. Visser MB, Majumdar S, Hani E, Sokol PA, (2004) Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect Immun 72: 2850-2857.
42. Lameignere E, Malinovska L, Slavikova M, Duchaud E, Mitchell EP, et al. (2008) Structural basis for mannose recognition by a lectin from opportunistic bacteria Burkholderia cenocepacia. Biochem J 411: 307-318.
43. Lameignere E, Shiao TC, Roy R, Wimmerova M, Dubreuil F, et al. (2010) Structural basis of the affinity for oligomannosides and analogs displayed by BC2L-A, a Burkholderia cenocepacia soluble lectin. Glycobiology 20: 87-98.
44. Sulak O, Cioci G, Delia M, Lahmann M, Varrot A, et al. (2010) A TNF-like trimeric lectin domain from Burkholderia cenocepacia with specificity for fucosylated human histo-blood group antigens. Structure 18: 59-72.
45. Tomich M, Herfst CA, Golden JW, Mohr CD, (2002) Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun 70: 1799-1806.
46. Urban TA, Goldberg JB, Forstner JF, Sajjan US, (2005) Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun 73: 5426-5437.
47. Evans E, Poxton IR, Govan JR, (1999) Lipopolysaccharide chemotypes of Burkholderia cepacia. J Med Microbiol 48: 825-832.
48. Eggers CT, Murray IA, Delmar VA, Day AG, Craik CS, (2004) The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase. Biochem J 379: 107-118.
49. Jelsbak L, Johansen HK, Frost AL, Thogersen R, Thomsen LE, et al. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 2214-2224.
50. Brown SA, Palmer KL, Whiteley M, (2008) Revisiting the host as a growth medium. Nat Rev Microbiol 6: 657-666.
51. Oberhardt MA, Goldberg JB, Hogardt M, Papin JA, (2010) Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J Bacteriol 192: 5534-5548.
52. Palmer KL, Aye LM, Whiteley M, (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 8079-8087.
53. Palmer KL, Mashburn LM, Singh PK, Whiteley M, (2005) Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187: 5267-5277.
54. Itoh Y, Nakada Y, (2004) Arginine and Polyamine Metabolism. In: Ramos JL, editors. Pseudomonas: Biosynthesis of Macromolecules and Molecular Metabolism New York Kluwer Academic.
55. Hagins JM, Scoffield JA, Suh SJ, Silo-Suh L, (2010) Influence of RpoN on isocitrate lyase activity in Pseudomonas aeruginosa. Microbiology 156: 1201-1210.
56. Lorenz MC, Fink GR, (2002) Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot Cell 1: 657-662.
57. Lindsey TL, Hagins JM, Sokol PA, Silo-Suh LA, (2008) Virulence determinants from a cystic fibrosis isolate of Pseudomonas aeruginosa include isocitrate lyase. Microbiology 154: 1616-1627.
58. Saldias MS, Valvano MA, (2009) Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology 155: 2809-2817.
59. Ratledge C, Dover LG, (2000) Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 54: 881-941.
60. Whitby PW, Vanwagoner TM, Springer JM, Morton DJ, Seale TW, et al. (2006) Burkholderia cenocepacia utilizes ferritin as an iron source. J Med Microbiol 55: 661-668.
61. Kida Y, Shimizu T, Kuwano K, (2011) Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice. Infect Immun 79: 211-219.
62. Alvarez-Ortega C, Harwood CS, (2007) Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol 65: 153-165.
63. Mil-Homens D, Rocha EP, Fialho AM, (2010) Genome-wide analysis of DNA repeats in Burkholderia cenocepacia J2315 identifies a novel adhesin-like gene unique to epidemic-associated strains of the ET-12 lineage. Microbiology 156: 1084-1096.
64. Bernier SP, Sokol PA, (2005) Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia. J Bacteriol 187: 5278-5291.
65. Saldias MS, Ortega X, Valvano MA, (2009) Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J Med Microbiol 58: 1542-1548.
66. Xia B, Royall JA, Damera G, Sachdev GP, Cummings RD, (2005) Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology 15: 747-775.
67. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, et al. (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180: 138-145.
68. Coenye T, Van Acker H, Peeters E, Sass A, Buroni S, et al. (2011) Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob Agents Chemother 55: 1912-1919.
69. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, et al. (2000) Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44: 2242-2246.
70. Sobel ML, McKay GA, Poole K, (2003) Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 47: 3202-3207.
71. Jeannot K, Sobel ML, El Garch F, Poole K, Plesiat P, (2005) Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction. J Bacteriol 187: 5341-5346.
72. Bryan LE, O'Hara K, Wong S, (1984) Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 26: 250-255.
73. Malott RJ, Baldwin A, Mahenthiralingam E, Sokol PA, (2005) Characterization of the cciIR quorum-sensing system in Burkholderia cenocepacia. Infect Immun 73: 4982-4992.
74. O'Grady EP, Viteri DF, Malott RJ, Sokol PA, (2009) Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC Genomics 10: 441.
75. O'Grady EP, Nguyen DT, Weisskopf L, Eberl L, Sokol PA, (2011) The Burkholderia cenocepacia LysR-type transcriptional regulator ShvR influences expression of quorum-sensing, protease, type II secretion, and afc genes. J Bacteriol 193: 163-176.
76. Cunha MV, Leitao JH, Mahenthiralingam E, Vandamme P, Lito L, et al. (2003) Molecular Analysis of Burkholderia cepacia Complex Isolates from a Portuguese Cystic Fibrosis Center: a 7-Year Study. Journal of Clinical Microbiology 41: 4113-4120.
77. Martins M, Santos B, Martins A, Viveiros M, Couto I, et al. (2006) An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo 20: 657-664.
78. Loutet SA, Valvano MA, (2010) A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun 78: 4088-4100.